• Something wrong with this record ?

Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease

O. Zakiyanov, M. Kalousová, T. Zima, V. Tesař

. 2021 ; 105 (-) : 141-212. [pub] 20210309

Language English Country United States

Document type Journal Article, Review

Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell surface components and regulate multiple cellular processes, cell to cell interactions, cell proliferation, and cell signaling pathways. MMPs function in close interaction with the endogenous tissue inhibitors of matrix metalloproteinases (TIMPs), both of which regulate cell turnover, modulate various growth factors, and participate in the progression of tissue fibrosis and apoptosis. The multiple roles of MMPs and TIMPs are continuously elucidated in kidney development and repair, as well as in a number of kidney diseases. This chapter focuses on the current findings of the significance of MMPs and TIMPs in a wide range of kidney diseases, whether they result from kidney tissue changes, hemodynamic alterations, tubular epithelial cell apoptosis, inflammation, or fibrosis. In addition, the potential use of these endopeptidases as biomarkers of renal dysfunction and as targets for therapeutic interventions to attenuate kidney disease are also explored in this review.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004677
003      
CZ-PrNML
005      
20220127145050.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/bs.acc.2021.02.003 $2 doi
035    __
$a (PubMed)34809827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zakiyanov, Oskar $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Electronic address: oskar.zakiyanov@lf1.cuni.cz
245    10
$a Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease / $c O. Zakiyanov, M. Kalousová, T. Zima, V. Tesař
520    9_
$a Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell surface components and regulate multiple cellular processes, cell to cell interactions, cell proliferation, and cell signaling pathways. MMPs function in close interaction with the endogenous tissue inhibitors of matrix metalloproteinases (TIMPs), both of which regulate cell turnover, modulate various growth factors, and participate in the progression of tissue fibrosis and apoptosis. The multiple roles of MMPs and TIMPs are continuously elucidated in kidney development and repair, as well as in a number of kidney diseases. This chapter focuses on the current findings of the significance of MMPs and TIMPs in a wide range of kidney diseases, whether they result from kidney tissue changes, hemodynamic alterations, tubular epithelial cell apoptosis, inflammation, or fibrosis. In addition, the potential use of these endopeptidases as biomarkers of renal dysfunction and as targets for therapeutic interventions to attenuate kidney disease are also explored in this review.
650    _2
$a extracelulární matrix - proteiny $7 D016326
650    _2
$a lidé $7 D006801
650    12
$a nemoci ledvin $7 D007674
650    _2
$a matrixové metaloproteinasy $x metabolismus $7 D020782
650    _2
$a signální transdukce $7 D015398
650    12
$a tkáňové inhibitory metaloproteinas $x metabolismus $7 D019714
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kalousová, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Tesař, Vladimír $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
773    0_
$w MED00182955 $t Advances in clinical chemistry $x 2162-9471 $g Roč. 105, č. - (2021), s. 141-212
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34809827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145047 $b ABA008
999    __
$a ok $b bmc $g 1751982 $s 1155826
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 105 $c - $d 141-212 $e 20210309 $i 2162-9471 $m Advances in clinical chemistry $n Adv Clin Chem $x MED00182955
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...